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Abstract
Primary intra-abdominal malignant mesenchymal tumours are very rare and there are not many
cases of visceral malignant fibrous histiocytoma in the English literature. We report a new case of
abdominal malignant fibrous histiocytoma presenting as abdominal pain and pyrexia of unknown
origin in a 54 year old female followed by a brief review of literature. Presentation with pyrexia of
unknown origin is extremely rare in this condition.
Background
The term Malignant Fibrous Histiocytoma (MFH) was
originally described by O'Brien and Stout in 1964 [1] to
cover a variety of pleomorphic soft tissue sarcomas
derived from histiocytes capable of fibroblastic transfor-
mation. MFH is a common sarcoma of mesenchymal ori-
gin affecting soft tissues of the body, especially the
extremities and retroperitoneum. Primary intra-abdomi-
nal MFH is a rare disease and few cases are reported in the
English literature. Its presentation as high-grade pyrexia of
unknown origin (PUO) is extremely unusual. We report a
case of malignant fibrous histiocytoma affecting colon,
spleen, left hemi diaphragm and distal pancreas in a 54
year old female, who presented with abdominal pain and
pyrexia of unknown origin.
Case report
A 54 year old female presented to our surgical outpatient
clinic with abdominal pain and pyrexia. Abdominal pain
was of recent onset and mainly in the left upper abdomen
but she had fever for at least 6 months. Her pyrexia was
high grade (39.5–40 C0), intermittent, and most common
in the early morning. Clinical examination revealed a
firm, vaguely defined, tender mass in the left upper quad-
rant of the abdomen. Blood results showed persistently
high ESR (>100), high CRP (>240), leukocytosis, mildly
raised Alkaline Phosphatase and anaemia (normochro-
mic, normocytic). There was no overt source of infection
that could account for the fever. Repeated blood cultures
did not yield any bacterial growth. NM Leukocyte
HMPAO scan showed no convincing abnormality to help
localise an infective focus. There was no improvement in
pyrexia after treating the patient with broad-spectrum
antibiotics.
CT scan of the abdomen was performed which showed
three heterogeneous masses in left upper abdomen relat-
ing to splenic flexure of colon, pancreatic body and tail
and left crus of the diaphragm (figure 1). There was evi-
dence of central necrosis in two of these masses. A trucut
biopsy of the mass was performed and histology revealed
spindle cell leiomyosarcoma.
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The patient was consented for surgery and distal pancrea-
tectomy, splenectomy, left adrenalectomy and resection
of part of colon was undertaken to remove the tumour via
a left thoracoabdominal approach. The patient had an
uneventful post-operative recovery and her pyrexia
resolved completely following surgery.
Three different specimens were submitted for histology.
Specimen A had a smooth external surface, measured 180
× 140 × 130 mm and comprised of a multi-nodular mass
with spleen and a loop of large bowel. The cut surface of
the tumour was grey with large areas of necrosis up to
80%. The bowel segment appeared to be entrapped and
focally infiltrated by the tumour up to the mucosa; how-
CT scan of abdomen showing extent of primary tumour Figure 1
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ever, both cut ends margins were free of tumour. Speci-
men B comprised of lobulated mass with fatty tissue and
measured 140 × 60 × 30 mm. Some adrenal tissue was
identified which was not involved by the tumour. Speci-
men C consisted of four pieces of haemorrhagic tissue.
Microscopically, specimen A showed a mixture of pat-
terns; in some areas, spindle cells with hyalinisation and
in other, pleomorphic cells mixed tumour and osteoclast
giant cells. Focally, tumour cells had long thin cytoplas-
mic processes and wavy nuclei. In addition, there was a
prominent inflammatory cell infiltrate in the background
with foamy histiocytes. Also, the nuclear atypia was
marked with a brisk mitotic activity. Immunohistochem-
istry of the tumour showed smooth muscle actin (SMA) to
be focally positive, but Desmin, CD34, S-100, Neurofila-
ment, EMA, CAM 5.2, CD117, CD21 and CD23 were neg-
ative. All these appearances were suggestive of a high-
grade sarcoma with no discernible line of differentiation;
hence it was best classified as grade 3 malignant fibrous
histiocytoma. Specimen B showed spindle cell sarcoma
with cells showing elongated thin cytoplasmic processes
and wavy nuclei. Specimen C showed spindle-pleomor-
phic sarcoma (Figure 2).
Two months following resection of the tumour, the
patient again developed high-grade fever. This was associ-
ated with left shoulder pain and weight loss. Investiga-
tions showed anaemia and hypercalcaemia. On CT
scanning, she was found to have local recurrence of the
tumour (figure 3) as well as liver metastases (figure 4). At
Histopathology image showing spindle to pleomorphic sarcoma with nuclear atypia and mitotic activity Figure 2
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this stage, patient was referred to the oncology depart-
ment but unfortunately died 8 weeks later.
Discussion
Malignant Fibrous Histiocytoma is a sarcoma of mesen-
chymal origin affecting soft tissues of the body, particu-
larly the extremities and retroperitoneum. Rarely, it may
affect intra-peritoneal organs. Its occurrence has been
reported in almost all parts of the body including head
and neck [2], intracranial [3,4], intra-abdominal organs
[5,6] and heart muscle [7]. It is considered as the most
common soft tissue sarcoma of the adults [8], but may
occur in children as well as infants [9].
The mode of presentation of MFH depends on the pri-
mary site of the body affected by the tumour, for example,
CT scan of abdomen showing local recurrence of the tumour Figure 3
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dyspnoea and arrhythmias can be caused by cardiac
lesions. In addition, symptoms of systemic illness caused
by the tumour may also be the presenting complaint.
Reporting our patient, intra-abdominal MFH presented as
pyrexia of unknown origin, caused likely by tumour
necrosis and release of inflammatory and pyrogenic fac-
tors.
On the basis of its wide range of histological appearances,
Enzinger and Weiss subdivided MFH into five sub-types
[10,11]:
1. Storiform-pleomorphic
2. myxoid (myxofibrosarcoma)
CT scan of abdomen showing liver metastases Figure 4
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3. Giant cell (malignant giant cell tumor of soft parts and
has the worst prognosis)
4. Inflammatory (xanthosarcoma and malignant xan-
thogranuloma)
5. Angiomatoid.
Investigations for the diagnosis of MFH include routine
haematological, biochemical and radiological tests. A CT
scan of the abdomen should be performed early in a
patient who presents with abdominal pain and pyrexia of
unknown origin but no obvious source of symptoms. This
can help identify and localise tumours, if and define
extent of growth and presence of metastatic disease. The
final diagnosis of MFH is based primarily on the his-
topathological examination and immunohistochemical
reactivity. These diagnostic procedures rely on several cri-
teria, which include the presence of typical spindle and
polygonal (strap-like) cells that are filled with an abun-
dant eosinophilic cytoplasm, cells with cross-striations,
and, particularly, desmin- and myoglobin-positive immu-
noreactivity [12,13]. However, the presence of cytoplas-
mic filaments is not always found in MFH and makes it
harder to establish a reliable differential diagnosis.
MFH is an aggressive tumour with a high potential of
metastasis to other parts of the body. The Liver is the most
commonly involved site of metastatic sarcomas, occurring
in 64%–70% of patients [15,16]. The current treatment of
choice for primary malignant fibrous histiocytomas is sur-
gical resection [14,15], which involves wide excision of
the tumour with an aim for tumour free margins. Recur-
rence of the tumour is not uncommon even when resec-
tion margins are tumour free. Metastasis may present
months or years after resection of the primary lesion.
Treatment for metastatic disease is surgical where possi-
ble; palliative surgery may be carried out if complete resec-
tion is not possible. The role of adjuvant radiotherapy and
chemotherapy is not clear in the case of retroperitoneal
and visceral sarcomas. There are studies that suggest no
improvement in overall survival after systemic chemo-
therapy [16-18]. Some advocate the use of chemoemboli-
zation for unresectable metastatic sarcomas, which can
provide durable tumour response [19].
Conclusion
In order to improve survival in patients with MFH, com-
plete resection of the primary tumour as well as isolated
peritoneal or hepatic metastases should be attempted
where possible. An early multidisciplinary approach is
important to improve clinical outcome. Our case report
shows that primary intra-abdominal MFH can present in
unusual ways including high-grade fever of unknown ori-
gin. Clinicians must remember this while establishing dif-
ferential diagnosis for patients with PUO and abdominal
pain.
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